Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome

  1. Luka Bacic
  2. Guillaume Gaullier
  3. Anton Sabantsev
  4. Laura C Lehmann
  5. Klaus Brackmann
  6. Despoina Dimakou
  7. Mario Halic
  8. Graeme Hewitt
  9. Simon Boulton
  10. Sebastian Deindl  Is a corresponding author
  1. Uppsala University, Sweden
  2. St Jude Children's Research Hospital, United States
  3. The Francis Crick Institute, United Kingdom

Abstract

The chromatin remodeler ALC1 is recruited to and activated by DNA damage-induced poly(ADP-ribose) (PAR) chains deposited by PARP1/PARP2/HPF1 upon detection of DNA lesions. ALC1 has emerged as a candidate drug target for cancer therapy as its loss confers synthetic lethality in homologous recombination-deficient cells. However, structure-based drug design and molecular analysis of ALC1 have been hindered by the requirement for PARylation and the highly heterogeneous nature of this post-translational modification. Here, we reconstituted an ALC1 and PARylated nucleosome complex modified in vitro using PARP2 and HPF1. This complex was amenable to cryo-EM structure determination without cross-linking, which enabled visualization of several intermediate states of ALC1 from the recognition of the PARylated nucleosome to the tight binding and activation of the remodeler. Functional biochemical assays with PARylated nucleosomes highlight the importance of nucleosomal epitopes for productive remodeling and reveal that ALC1 preferentially slides nucleosomes away from DNA breaks.

Data availability

The cryo-EM map of the ALC1-nucleosome complex in the active state was deposited at the EMDB with accession code EMD-13065. The model of the ALC1-nucleosome complex in the active state was deposited at the PDB with accession code 7OTQ. The map series from the cryoDRGN graph traversal was deposited at the EMDB with accession code EMD-13070. Raw movies, extracted particles and their coordinates, and cryoDRGN and cryoSPARC job directories were deposited in EMPIAR with accession code EMPIAR-10739.

Article and author information

Author details

  1. Luka Bacic

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6896-3506
  2. Guillaume Gaullier

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3405-6021
  3. Anton Sabantsev

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8559-8894
  4. Laura C Lehmann

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2518-5606
  5. Klaus Brackmann

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
  6. Despoina Dimakou

    Uppsala University, Uppsala, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1424-5469
  7. Mario Halic

    St Jude Children's Research Hospital, Memphis, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0061-7372
  8. Graeme Hewitt

    The Francis Crick Institute, London, United Kingdom
    Competing interests
    No competing interests declared.
  9. Simon Boulton

    The Francis Crick Institute, London, United Kingdom
    Competing interests
    Simon Boulton, is co-founder and VP Science Strategy at Artios Pharma Ltd..
  10. Sebastian Deindl

    Uppsala University, Uppsala, Sweden
    For correspondence
    sebastian.deindl@icm.uu.se
    Competing interests
    Sebastian Deindl, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6807-8654

Funding

European Research Council (714068)

  • Sebastian Deindl

Knut och Alice Wallenbergs Stiftelse (KAW 019.0306)

  • Sebastian Deindl

Vetenskapsrådet (VR Grant 2019-03534)

  • Sebastian Deindl

Cancerfonden (19 0055 Pj)

  • Sebastian Deindl

Cancer Research UK (FC0010048)

  • Simon Boulton

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Bacic et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,238
    views
  • 565
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Luka Bacic
  2. Guillaume Gaullier
  3. Anton Sabantsev
  4. Laura C Lehmann
  5. Klaus Brackmann
  6. Despoina Dimakou
  7. Mario Halic
  8. Graeme Hewitt
  9. Simon Boulton
  10. Sebastian Deindl
(2021)
Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome
eLife 10:e71420.
https://doi.org/10.7554/eLife.71420

Share this article

https://doi.org/10.7554/eLife.71420

Further reading

    1. Chromosomes and Gene Expression
    Carlos Moreno-Yruela, Beat Fierz
    Insight

    Specialized magnetic beads that bind target proteins to a cryogenic electron microscopy grid make it possible to study the structure of protein complexes from dilute samples.

    1. Chromosomes and Gene Expression
    Carmina Lichauco, Eric J Foss ... Antonio Bedalov
    Research Article

    The association between late replication timing and low transcription rates in eukaryotic heterochromatin is well known, yet the specific mechanisms underlying this link remain uncertain. In Saccharomyces cerevisiae, the histone deacetylase Sir2 is required for both transcriptional silencing and late replication at the repetitive ribosomal DNA (rDNA) arrays. We have previously reported that in the absence of SIR2, a de-repressed RNA PolII repositions MCM replicative helicases from their loading site at the ribosomal origin, where they abut well-positioned, high-occupancy nucleosomes, to an adjacent region with lower nucleosome occupancy. By developing a method that can distinguish activation of closely spaced MCM complexes, here we show that the displaced MCMs at rDNA origins have increased firing propensity compared to the nondisplaced MCMs. Furthermore, we found that both activation of the repositioned MCMs and low occupancy of the adjacent nucleosomes critically depend on the chromatin remodeling activity of FUN30. Our study elucidates the mechanism by which Sir2 delays replication timing, and it demonstrates, for the first time, that activation of a specific replication origin in vivo relies on the nucleosome context shaped by a single chromatin remodeler.